Cargando…
Does Adjunctive Tigecycline Improve Outcomes in Severe-Complicated, Nonoperative Clostridium difficile Infection?
Severe Clostridium difficile infection is associated with a high rate of mortality; however, the optimal treatment for severe- complicated infection remains uncertain for patients who are not candidates for surgical intervention. Thus, we sought to evaluate the benefit of adjunctive tigecycline in t...
Autores principales: | LaSalvia, Mary T., Branch-Elliman, Westyn, Snyder, Graham M., Mahoney, Monica V., Alonso, Carolyn D., Gold, Howard S., Wright, Sharon B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5413996/ https://www.ncbi.nlm.nih.gov/pubmed/28480257 http://dx.doi.org/10.1093/ofid/ofw264 |
Ejemplares similares
-
Tigecycline for the Treatment of Severe and Severe Complicated Clostridium difficile Infection
por: Britt, Nicholas S., et al.
Publicado: (2014) -
Health and Economic Burden of Post-Partum Staphylococcus aureus Breast Abscess
por: Branch-Elliman, Westyn, et al.
Publicado: (2013) -
Refractory Clostridium difficile Infection Successfully Treated with Tigecycline, Rifaximin, and Vancomycin
por: Lao, Dominador, et al.
Publicado: (2012) -
Bezlotoxumab for the prevention of Clostridium difficile infection: a review of current evidence and safety profile
por: Alonso, Carolyn D, et al.
Publicado: (2018) -
Discordance of SHEA/IDSA Clostridium difficile Disease Severity Scale in Solid Organ Transplant Patients
por: Lee, Tiffany, et al.
Publicado: (2017)